Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of tapentadol in severe chronic low back pain or severe chronic pain due to knee osteoarthritis
2009-015527-82Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tapentadol in chronic low back pain (CLBP) and knee osteoarthritis (OA), sponsored by Grünenthal GmbH. Primary endpoint: Long-term efficacy, tolerability, and safety assessments. Started Oct 2009; status: completed.
02
Drugs
tapentadol
03
Conditions
chronic low back pain (CLBP)knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-015527-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015527-82.